Day: January 5, 2022

Oxford Lane Capital Corp. Prices Public Offering of $87 Million 5.00% Notes Due 2027

Oxford Lane Capital Corp. Prices Public Offering of $87 Million 5.00% Notes Due 2027

GREENWICH, Conn., Jan. 05, 2022 (GLOBE NEWSWIRE) — Oxford Lane Capital Corp. (the “Company”) (NasdaqGS: OXLC, OXLCM, OXLCP, OXLCL and OXLCO) today announced that it has priced an underwritten public offering of $87 million in aggregate principal amount of 5.00% unsecured notes due 2027. The notes will mature on January 31, 2027, and may be redeemed in whole or in part at any time or from time to time at the Company’s option on or after January 31, 2024. The notes will bear interest at a rate of 5.00% per year payable quarterly on March 31, June 30, September 30, and December 31 of each year, commencing March 31, 2022. The offering is expected to close on January 13, 2022, subject to customary closing conditions. The Company has granted the underwriters an option to purchase up to an additional $13 million in aggregate principal...

Continue reading

Trigon Announces Private Placement Financing

Trigon Announces Private Placement Financing

NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Trigon Metals Inc. (TSX-V: TM) (“Trigon” or the “Company”) intends to complete a non-brokered private placement of up to 4,444,444 units (the “Units”) at a price of $0.45 per Unit for gross proceeds of up to $2,000,000 (the “Offering”). Each Unit is comprised of one common share of Trigon (a “Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder thereof to acquire one Share at a price of $0.50 for a period of 24 months following the date hereof, subject to an acceleration provision whereby in the event that at any time after the expiry of the statutory hold period, the Shares trade at $0.75 or higher on the TSX Venture Exchange...

Continue reading

Gerry Adest to Join Genesis HealthCare Board of Directors

Gerry Adest to Join Genesis HealthCare Board of Directors

KENNETT SQUARE, Pa., Jan. 05, 2022 (GLOBE NEWSWIRE) — Genesis Healthcare, Inc. (Genesis, or the Company) (OTC: GENN), a national post-acute care provider, announced today that effective January 10, 2022, Gerry Adest, CPA, will join the Company’s Board of Directors. Board Member Robert (“Bob”) H. Fish left the Board effective January 1, 2022.  “The Board and I would like to thank Bob who has graciously supported Genesis, its employees, patients, and residents in many capacities over the years and we are forever grateful for his leadership,” said David Harrington, Executive Chairman of the Board for Genesis. “We are also excited to welcome Gerry to our Board. Gerry is a well-known leader in the post-acute industry and his experience and insights will be valuable as we lead Genesis into the future.” Mr. Adest is a practicing CPA and...

Continue reading

Todos Medical CEO Provides Letter to Shareholders

Todos Medical CEO Provides Letter to Shareholders

New York, NY, and Tel Aviv, ISRAEL, Jan. 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, announced that its President & CEO Gerald Commissiong today issued a letter to shareholders outlining the Company progresses towards a national exchange listing expected in the first half of 2022. Dear Valued Shareholder, I would like to thank you for joining us in our journey here at Todos to transform the course of the COVID-19 pandemic and help patients with cancer and Alzheimer’s get better access to diagnostic tools that could dramatically impact their health. I’m going to touch on the key themes of great interest to our shareholders and hopefully set out the key plans we have that we believe will drive shareholder value in...

Continue reading

Verano Announces Conference Participation for January

Verano Announces Conference Participation for January

CHICAGO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that members of its executive leadership team will present at the following conferences: ICR ConferenceAaron Miles, Chief Investment Officer, will give a presentation.DATE: January 10, 2022TIME: 12:00 p.m. CT ATB 10th Annual Institutional Investor ConferenceGeorge Archos, Founder and Chief Executive Officer, will participate in a panel and one-on-one meetings.DATE: January 13, 2022TIME: 11:20 a.m. CTLINK: https://wsw.com/webcast/atb4/panel16/1834365 24th Annual Needham Growth ConferenceGeorge Archos, Founder and Chief Executive Officer, will participate in a fireside chat and one-on-one meetings.DATE: January 14, 2022TIME: 10:30 a.m. CTLINK: https://wsw.com/webcast/needham116/vrnof/2466222 About...

Continue reading

Stingray Expands its Retail Media Network to the United States with the Acquisition of InStore Audio Network

Stingray Expands its Retail Media Network to the United States with the Acquisition of InStore Audio Network

InStore Audio Network is the largest retail audio network in the US with 16,000 locations MONTREAL, Jan. 05, 2022 (GLOBE NEWSWIRE) — Stingray Group Inc. (TSX: RAY.A; RAY.B), a leading music, media, and technology company, today announced that it has acquired InStore Audio Network, the largest in-store audio advertising network in the United States, reaching 100 million shoppers each week in over 16,000 grocery retailers and pharmacies across the US for total consideration of up to approximately C$59 million subject to a specific earn out mechanism set forth in the purchase agreement. With this acquisition, Stingray expands its retail-based digital audio advertising footprint in the United States and reaffirms its position as a leading global provider of state-of-the art digital media solutions. InStore Audio Network generated an...

Continue reading

Genocea to Present at Upcoming Investor Conferences

Genocea to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Jan. 05, 2022 (GLOBE NEWSWIRE) — Genocea Biosciences, Inc. (Nasdaq: GNCA), a biopharmaceutical company developing next-generation neoantigen immunotherapies, announced that senior leadership plans to present at the following conferences in January. Conferences: Event: Longwood Healthcare Leaders Winter Webconference – Details Topic 1: Innovation in Cell Therapy Format: Panel Date: Thursday, January 6, 2022 Time: 1:30 PM ET Topic 2: Making a Big Impact With Limited Resources Format:Date:Time: PanelThursday, January 6, 20225:10 PM ET Event: LifeSci Partners 11th Annual Corporate Access Event – Details Topic 1: Innovative Approaches to Cell Therapy for Oncology Format: Panel Date: Friday, January 7, 2022 Time: 8:30 AM ET Topic 2: Cancer Vaccines: Promises, Promises … Has Their...

Continue reading

NOW OPEN: Hospital for Endocrine Surgery, A Part of HCA Florida South Tampa Hospital

NOW OPEN: Hospital for Endocrine Surgery, A Part of HCA Florida South Tampa Hospital

Specialized treatments and services at one convenient location Hospital for Endocrine Surgery, A Part of HCA Florida South Tampa Hospital Providing specialized treatments and services in one convenient location. Healing Environment Providing patients from around the country and the world specialized inpatient and outpatient surgical care, conveniently located near Tampa International Airport. Tampa, Jan. 05, 2022 (GLOBE NEWSWIRE) — This week, HCA Florida Healthcare’s West Florida Division proudly announced the Jan. 3 grand opening of the Hospital for Endocrine Surgery, A part of HCA Florida South Tampa Hospital, a first of its kind program dedicated to endocrine surgery. The first surgical cases were performed Monday. Since opening, the hospital has cared for patients who traveled from as far as Mexico...

Continue reading

Xometry to Participate in the 24th Annual Needham Virtual Growth Conference

Xometry to Participate in the 24th Annual Needham Virtual Growth Conference

ROCKVILLE, Md., Jan. 05, 2022 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ:XMTR), a leading AI-enabled marketplace for on-demand manufacturing, today announced that senior management will attend the 24th Annual Needham Virtual Growth Conference on Friday, Jan. 14 including an investor presentation.  A webcast of the presentation will be accessible within the Investor Relations section of Xometry’s website. An archived replay of the webcast will be available following the live presentation. About XometryXometry is a leading AI-enabled marketplace for on-demand manufacturing, transforming one of the largest industries in the world. Xometry uses its proprietary technology to create a marketplace that enables buyers to efficiently source on-demand manufactured parts and assemblies, and empowers sellers of manufacturing services to grow...

Continue reading

Galane Gold Ltd. Announces Management Change

Galane Gold Ltd. Announces Management Change

TORONTO, Jan. 05, 2022 (GLOBE NEWSWIRE) — Galane Gold Ltd. (“Galane Gold” or the “Company”) (TSX-V: GG; OTCQB: GGGOF) today announces that it has issued to Gavin Vandervegt a notice to terminate his contract as the Company’s Chief Financial Officer. Mr. Vandervegt has served as Galane Gold’s CFO since October 2016 and he will remain with the Company in a transitional role for a period of up to three months. “We would like to thank Gavin for his tireless and invaluable contributions to Galane Gold,” said Nick Brodie, Chief Executive Officer. “We wish him all the best in his future endeavours.” Ravi Sood, the Chairman of Galane Gold, said in addition, “The Galane Gold board of directors is currently undertaking a review of its senior management team with a view to aligning it closer with the Company’s growth plans over the next two...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.